ストックスクリーナーアプリを入手
12.00
0.17%
-0.02
アフターアワーズ：
11.98
-0.02
-0.17%
前日終値:
$12.02
開ける：
$12.1
24時間の取引高:
91,999
Relative Volume:
0.72
時価総額：
$365.08M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-7.76%
1か月 パフォーマンス:
+4.80%
6か月 パフォーマンス:
-21.16%
1年 パフォーマンス:
-13.17%
1日の値動き範囲:
$11.98
$12.18
1週間の範囲:
$11.88
$13.09
52週間の値動き範囲:
$10.55
$15.90
Abrdn Life Sciences Investors Stock (HQL) Company Profile
HQL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
12.00 | 365.08M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.63 | 3.55B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
33.66 | 2.93B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
25.59 | 2.46B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
19.27 | 2.27B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
14.25 | 2.24B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors (HQL) 最新ニュース
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Grows By 46.5% - MarketBeat
AQR Arbitrage LLC Has $2.47 Million Stake in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 26.2% in April - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Shares Sold by AQR Arbitrage LLC - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Stock Position Increased by Invesco Ltd. - Defense World
Raymond James Financial Inc. Invests $3.13 Million in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Quarry LP - MarketBeat
Quarry LP Lowers Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount - Yahoo
Walleye Capital LLC Invests $477,000 in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update - ACCESS Newswire
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Increases By 26.3% - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 9,144 Shares - MarketBeat
937,656 Shares in Abrdn Healthcare Investors (NYSE:HQH) Purchased by Raymond James Financial Inc. - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Down 26.0% in March - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by 1607 Capital Partners LLC - MarketBeat
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Short Interest Update - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $179,718.00 in Stock - MarketBeat
Saba Capital Management, L.P. Sells 30,156 Shares of Abrdn Life Sciences Investors (NYSE:HQL) Stock - MarketBeat
Short Interest in Abrdn Healthcare Investors (NYSE:HQH) Declines By 26.0% - Defense World
Saba capital management sells $179,718 in Abrdn life sciences stock - Investing.com Australia
Series CGlycomine - Crunchbase
Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG - Business Wire
LPL Financial LLC Has $3.77 Million Holdings in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock - Investing.com Australia
Saba capital management sells $179,718 in Abrdn life sciences stock By Investing.com - Investing.com South Africa
LPL Financial LLC Raises Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock By Investing.com - Investing.com South Africa
Abrdn Healthcare Investors (NYSE:HQH) Reaches New 1-Year LowTime to Sell? - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 6,889 Shares - MarketBeat
Abrdn Life Sciences Investors (HQL) 財務データ
Abrdn Life Sciences Investors (HQL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.36%
0.28%
大文字化:
|
ボリューム (24 時間):